Subtopic Deep Dive
Gut Microbiota in IBD Pathogenesis
Research Guide
What is Gut Microbiota in IBD Pathogenesis?
Gut microbiota dysbiosis in IBD pathogenesis involves reduced microbial diversity, depletion of Faecalibacterium prausnitzii, and enrichment of adherent-invasive Escherichia coli in Crohn's disease and ulcerative colitis.
16S rRNA sequencing and metagenomics reveal lower alpha diversity in treatment-naive Crohn's patients (Gevers et al., 2014, 3181 citations). Functional dysmetabolism links microbiota shifts to immune dysregulation (Morgan et al., 2012, 2686 citations). Over 30 GWAS studies confirm host-microbe genetic interactions (Jostins et al., 2012, 4764 citations).
Why It Matters
Gut microbiota research guides FMT trials showing 50% remission in UC (Sokol et al. referenced in Morgan et al., 2012). Probiotic targets like F. prausnitzii restore butyrate production, reducing inflammation (Manichanh et al., 2005). Genetic loci from Jostins et al. (2012) prioritize microbial modulators for precision therapy. Global IBD burden rose 67% from 1990-2017, demanding microbiota-based interventions (Alatab et al., 2019).
Key Research Challenges
Establishing Microbial Causality
Distinguishing dysbiosis as cause versus consequence of inflammation remains unresolved. Animal models and FMT trials provide evidence but human causality requires longitudinal multi-omics (Gevers et al., 2014). Confounders like diet and antibiotics complicate interpretations (Morgan et al., 2012).
Inter-Individual Variability
Microbiota composition varies by geography, diet, and genetics, hindering universal biomarkers. Metagenomic studies show inconsistent pathogen enrichment across cohorts (Manichanh et al., 2005). Personalized profiling demands large-scale integration (Jostins et al., 2012).
Functional Pathway Mapping
Linking taxa shifts to metabolic outputs like short-chain fatty acids requires integrated metabolomics. Current sequencing misses strain-level resolution (Kostic et al., 2014). Therapy design needs precise pathway targets (Zhang, 2014).
Essential Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins, Stephan Ripke, Rinse K. Weersma et al. · 2012 · Nature · 4.8K citations
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Dirk Gevers, Subra Kugathasan, Lee A. Denson et al. · 2014 · Cell Host & Microbe · 3.2K citations
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Xochitl C. Morgan, Timothy L. Tickle, Harry Sokol et al. · 2012 · Genome biology · 2.7K citations
Abstract Background The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis result from alterations in intestinal microbes and the immune system. However, the precise dysfuncti...
Inflammatory Bowel Disease
Clara Abraham, Judy H. Cho · 2009 · New England Journal of Medicine · 2.6K citations
system in health and then focus on advances in our understanding of how genetic alterations in this system contribute to the development of inflammatory bowel disease.
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Chaysavanh Manichanh, L Rigottier-Gois, E Bonnaud et al. · 2005 · Gut · 2.2K citations
Background and aim: A role for the intestinal microbial community (microbiota) in the onset and chronicity of Crohn’s disease (CD) is strongly suspected. However, investigation of such a complex ec...
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
Janelle C. Arthur, Ernesto Peréz-Chanona, Marcus Mühlbauer et al. · 2012 · Science · 2.2K citations
Of Microbes and Cancer Inflammation is a well-established driver of tumorigenesis. For example, patients with inflammatory bowel disease have an elevated risk of developing colorectal cancer (CRC)....
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Sudabeh Alatab, Sadaf G Sepanlou, Kevin S Ikuta et al. · 2019 · The Lancet. Gastroenterology & hepatology · 2.1K citations
Bill & Melinda Gates Foundation.
Reading Guide
Foundational Papers
Start with Jostins et al. (2012) for genetic architecture shaped by microbes (4764 citations), then Gevers et al. (2014) for naive CD microbiome (3181 citations), followed by Morgan et al. (2012) for functional insights (2686 citations).
Recent Advances
Study Kostic et al. (2014) on microbiome status (1723 citations) and Kaplan & Windsor (2020) on epidemiological stages (1138 citations) for therapy translation.
Core Methods
Core techniques: 16S rRNA amplicon sequencing for diversity (Manichanh et al., 2005), shotgun metagenomics for pathways (Morgan et al., 2012), GWAS for host-microbe links (Jostins et al., 2012).
How PapersFlow Helps You Research Gut Microbiota in IBD Pathogenesis
Discover & Search
Research Agent uses searchPapers('gut microbiota dysbiosis IBD 16S metagenomics') to retrieve Gevers et al. (2014), then citationGraph reveals 3181 forward citations including Kostic et al. (2014). exaSearch uncovers unpublished preprints on FMT causality, while findSimilarPapers expands to Manichanh et al. (2005) metagenomic diversity metrics.
Analyze & Verify
Analysis Agent runs readPaperContent on Morgan et al. (2012) to extract dysmetabolism pathways, verifies diversity claims with runPythonAnalysis on 16S alpha-diversity stats using pandas/Shannon index. GRADE grading scores Gevers et al. (2014) evidence as high for causality; CoVe cross-checks against Jostins et al. (2012) GWAS data.
Synthesize & Write
Synthesis Agent detects gaps in strain-level causality post-Gevers et al. (2014), flags contradictions between diversity loss in Manichanh et al. (2005) and treatment effects (Morgan et al., 2012). Writing Agent applies latexEditText for IBD pathogenesis review, latexSyncCitations integrates 10 papers, latexCompile generates PDF; exportMermaid visualizes microbiota-immune interaction networks.
Use Cases
"Analyze alpha diversity stats from Gevers 2014 Crohn's microbiome dataset"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis(pandas Shannon index on 16S data) → matplotlib plots of case vs control diversity.
"Draft LaTeX review on microbiota dysbiosis in IBD with citations"
Synthesis Agent → gap detection → Writing Agent → latexEditText(structured sections) → latexSyncCitations(Jostins 2012 et al.) → latexCompile → PDF review.
"Find GitHub repos analyzing IBD 16S sequencing pipelines"
Research Agent → paperExtractUrls(Gevers 2014) → Code Discovery → paperFindGithubRepo → githubRepoInspect → QIIME2 workflow scripts.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'Faecalibacterium prausnitzii IBD', chains citationGraph → readPaperContent → GRADE → structured report on butyrate pathways. DeepScan applies 7-step CoVe to verify Gevers et al. (2014) dysbiosis causality against confounders. Theorizer generates hypotheses linking Jostins et al. (2012) genetics to microbial targets.
Frequently Asked Questions
What defines gut microbiota dysbiosis in IBD?
Dysbiosis features reduced alpha diversity, depleted F. prausnitzii, and increased Proteobacteria in CD and UC (Gevers et al., 2014; Manichanh et al., 2005).
What methods study microbiota in IBD?
16S rRNA sequencing detects taxa shifts; metagenomics profiles functions; metabolomics links to SCFAs (Morgan et al., 2012; Gevers et al., 2014).
What are key papers on this topic?
Jostins et al. (2012, 4764 citations) on genetic-microbe interactions; Gevers et al. (2014, 3181 citations) on treatment-naive CD microbiome; Morgan et al. (2012, 2686 citations) on functional dysfunction.
What open problems exist?
Causality proof via human trials, strain-level resolution, and integration with host genetics remain unsolved (Kostic et al., 2014; Jostins et al., 2012).
Research Inflammatory Bowel Disease with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Gut Microbiota in IBD Pathogenesis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the Inflammatory Bowel Disease Research Guide